ABBONDANZA, Ciro
 Distribuzione geografica
Continente #
EU - Europa 7.133
NA - Nord America 3.210
AS - Asia 2.577
SA - Sud America 323
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 13.282
Nazione #
RU - Federazione Russa 3.675
US - Stati Uniti d'America 3.170
IT - Italia 1.090
SG - Singapore 896
IE - Irlanda 796
CN - Cina 717
UA - Ucraina 366
HK - Hong Kong 353
GB - Regno Unito 303
DE - Germania 289
BR - Brasile 270
FR - Francia 196
KR - Corea 176
SE - Svezia 138
VN - Vietnam 131
FI - Finlandia 115
TR - Turchia 95
IN - India 87
GR - Grecia 57
JP - Giappone 43
BE - Belgio 25
CA - Canada 24
NL - Olanda 23
AR - Argentina 22
BD - Bangladesh 17
AT - Austria 12
MX - Messico 11
ZA - Sudafrica 11
IR - Iran 10
PK - Pakistan 10
PY - Paraguay 10
IQ - Iraq 9
CH - Svizzera 8
EC - Ecuador 7
ES - Italia 7
MA - Marocco 7
ID - Indonesia 6
PL - Polonia 6
CO - Colombia 5
RO - Romania 5
AL - Albania 4
CZ - Repubblica Ceca 4
EU - Europa 4
IL - Israele 4
AZ - Azerbaigian 3
HN - Honduras 3
HU - Ungheria 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
LT - Lituania 3
SA - Arabia Saudita 3
VE - Venezuela 3
AU - Australia 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
LB - Libano 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
IM - Isola di Man 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
RS - Serbia 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.282
Città #
Moscow 1.306
Dublin 796
Jacksonville 545
Chandler 534
Santa Clara 436
Singapore 428
Hong Kong 353
Seoul 176
Ann Arbor 136
Caserta 122
Hefei 113
Beijing 108
Ashburn 101
Princeton 100
Boardman 91
Bremen 91
Bengaluru 75
Medford 72
Rome 72
Naples 71
Roxbury 67
Cambridge 64
Woodbridge 62
Milan 53
Ho Chi Minh City 43
San Mateo 42
Nanjing 41
Wilmington 41
The Dalles 37
Munich 35
New York 33
Hanoi 30
Düsseldorf 29
Dallas 28
São Paulo 28
Venice 26
Brussels 25
Los Angeles 23
Nanchang 22
Bari 21
Des Moines 18
Helsinki 17
Jinan 17
Napoli 17
Shenyang 14
Mountain View 13
Tianjin 13
Auburn Hills 12
Florence 12
Kunming 12
Pozzuoli 12
Brooklyn 10
Buffalo 10
Guangzhou 10
Norwalk 10
Nuremberg 10
Aversa 9
Lanzhou 9
Catania 8
Chicago 8
Guarulhos 8
Hanover 8
Rio de Janeiro 8
Salerno 8
San Nicola la Strada 8
Secaucus 8
Zhengzhou 8
Boston 7
Cerami 7
Hebei 7
Porto Alegre 7
Rockville 7
Shanghai 7
Toronto 7
Zanjan 7
Bologna 6
Ferrara 6
Haikou 6
Hangzhou 6
London 6
Padova 6
Palermo 6
Poggiomarino 6
Salvador 6
Tokyo 6
Turku 6
Amsterdam 5
Belo Horizonte 5
Caivano 5
Campinas 5
Casoria 5
Charlotte 5
Falkenstein 5
Frattaminore 5
Houston 5
Hải Dương 5
Istanbul 5
Mexico City 5
Piedimonte San Germano 5
Seattle 5
Totale 6.965
Nome #
Analisi delle sottopopolazioni linfocitarie nel trattamento cortisonico 590
Immunità innata: le prime linee di difesa 243
Immunobiologia di Janeway 222
A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis 184
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 182
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 177
An aprotinin binding site localized in the hormone binding domain of the estrogen receptor from calf uterus 173
17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells. 168
Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor 167
Le basi dell'immunologia. Fisiopatologia del sistema immunitario 162
Aprotinin inhibits the hormone binding of the estrogen receptor from calf uterus 161
Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells 158
Estradiol induces functional inactivation of p53 by intracellular redistribution 156
Estradiol receptor has proteolytic activity that is responsible for its own transformation 156
Antibodies anti-p53 serological detection with ELISA method. 154
Anti-p53 antibodies detection in cancer patients. 152
Studio dell’interazione tra il recettore dell’estradiolo e proteine di estratti nucleari da HeLa ed MCF-7 152
Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration. 151
Purified estrogen receptor enhances in vitro transcription 151
Regulation of p53 function in normal and malignant cells 150
Antiproliferative effects of SOM 230 in EPN prostate cell line 144
Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues 142
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 141
ANTI-ONCOGENIC ACTION OF ESTRADIOL IN EPN, A NONTRANSFORMED PROSTATE EPITHELIAL CELL LINE: EFFECTS ON TUMOR SUPPRESSORS RB AND RIZ1 140
In vitro binding of the purified hormone-binding subunit of the estrogen receptor to oligonucleotides containing natural or modified sequences of an estrogen-responsive element 139
La capacità dell’ antioncogene p53 di legare specifiche sequenze di DNA è modulata in vitro dalla presenza di oligonucleotidi 139
Differentiation of myeloid cell lines correlates with a selective expression of RIZ protein 138
Proteomic analysis of MCF-7 cell lines expressing the zinc-finger or the proline-rich domain of retinoblastoma-interacting-zinc-finger protein 137
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 136
4) Purification of the estrogen receptor from calf uterus cytosol 136
DNA strend breaks induce the formation of p53 protein stable complexes with p53 target site and modifyits protease sensitivity 136
Meccanismi effettori dell’immunità umorale 134
Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells 133
In vitro binding of the purified hormone-binding subunit of the estrogen receptor to the estrogen responsive element of the vitellogenin gene 133
ANTIPROLIFERATIVE EFFECTS OF SOM230 AND OCTREOTIDE IN EPN PROSTATE CELL LINE. 133
L’acido all-trans retinoico e l’antiestrogeno ICI 182,780 promuovono apoptosi in cellule epiteliali estrogeno dipendenti (MCF-7) influenzando i livelli di Bcl-2 e p. 53 132
Rosacea and abatacept: the first report of a possible correlation 132
Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma 130
Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies 130
Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein 128
Identification of the Syrian hamster cardiomyopathy gene 128
Induzione da acido retinoico (All-trans retinoico) della proteina RIZ 1, prodotto del gene oncosoppressore RIZ, in cellule di leucemia promielocitica 128
Human PRDM2: Structure, function and pathophysiology 128
Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2 127
Short 5’protuding oligonucleotides enhance binding of p53 to specific DNA sequences 127
Proteolytic activity of the purified hormone-binding subunit of the estrogen receptor 127
17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence 127
Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell 125
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 125
Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription 124
Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein) 123
Multiple Sclerosis: From the Application of Oligoclonal Bands to Novel Potential Biomarkers 122
Prostate cancer stem cells: the role of androgen and estrogen receptors. 121
Does Gut-breast Microbiota Axis Orchestrates Cancer Progression? 120
Transcriptional control by nuclear receptor 120
Studio preliminare dell’espressione di TIM1, TIM3 e GITR sui linfociti T CD4+ di soggetti T- linfopenici e in terapia con interferone alfa 120
A proteomic analysis of protein expression pattern of MCF-7 cell lines transfected with the zinc-finger and proline-rich domain of retinoblastoma-interacting zinc-finger protein 119
Differentiation of Myeloid cell lines correlates with a selective expression of RIZ protein 119
Decreased serum vascular endothelial growth Factor-D (VEGF-D) levels in metastatic patients with differentiated thyroid carcinoma. 118
Short 5’protuding oligonucleotides enhance binding of p53 to specific DNA sequences 118
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 117
Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptorα and β 116
Immunità Innata 116
Immunità innata: le prime linee di difesa 116
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer. 115
Metal binding sites of the estradiol receptor from calf uterus and their possible role in the regulation of receptor function 115
Estrogen Induces Looping Between Tumor Suppressor RIZ Gene Promoter 2 with Exon 9a 115
Searching for a putative mechanism of tumor-promoting function of RIZ2 in cancer models 113
Identification and characterization of the protein product of the human homeotic gene c8 112
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation 111
ESTROGEN RECEPTOR α AND β EXPRESSION IN PRIMARY CULTURES OF NORMAL AND MALIGNANT PROSTATE EPITHELIAL CELLS . 110
Manifestazioni sistemiche dell'infiammazione (cap.16) 109
INTERACTION OF ESTROGEN RECEPTOR α WITH THE RETINOBLASTOMA-INTERACTING-ZING-FINGER GENE PRODUCT RIZ 109
Serum anti-p53 antibodies and progression of hepatic diseases HCV related. 108
EXPRESSION AND CELLULAR LOCALIZATION OF TUMOR SUPPRESSOR PROTEIN RIZ1 (RETINOBLASTOMA-INTERACTING ZINC-FINGER PROTEIN 1) IN PROSTATE TISSUES. 108
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 108
Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues 104
Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation 104
PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation 103
DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. 103
Regolazione dell’espressione di p53 p21(WAF-1/CIP1) e di Bcl-2 da parte dell’estradiolo, dell’acido all-trans retinico e dell’ICI 182,780 in cellule di carcinoma mammario 103
The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action 102
Retinoblastoma-Interacting Zinc-Finger protein (RIZ): un candidato tumor-suppressor effettore dell’azione degli estrogeni 100
Piccoli oligonucleotidi attivano la funzione di p53 modificando la sua affinità per specifiche sequenze di DNA 99
Expression of PRDM1/BLIMP1 and PRDM2/RIZ in the activation of T CD4+ naïve limphocytes 98
Pan-cancer mutational and transcriptional analysis of the integrator complex 98
Riz, Rb e p53, tre nuovi possibili markers dell’azione dell’estradiolo in cellule di carcinoma mammario 97
Tumor suppressor protein RIZ1 expression is regulated by DHT in prostate epithelial cells 97
DIFFERENT EXPRESSION OF ESTROGEN RECEPTOR α AND β IN PRIMARY CULTURES OF NORMAL AND MALIGNANT HUMAN PROSTATE EPITHELIAL CELLS 97
PRDM Gene Products in Testicular Germ Cell Tumors 97
Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework 95
The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation 93
ESTROGEN RECEPTOR α and β EXPRESSION AND IMMUNOREACTIVITY IN NORMAL AND CANCER HUMAN PROSTATES 91
ESPESSIONE DEL TUMOR SUPPRESSOR RIZ1 IN CELLULE EPITELIALI NORMALI E MALIGNE DI PROSTATA 89
Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines 89
Multifaceted role of PRDM proteins in human cancer 89
Mouse monoclonal antibodies against estrogen receptor 88
EXPRESSION OF RIZ1 TUMOR SUPPRESSOR IN NORMAL AND MALIGNANT PROSTATE EPITHELIAL CELLS 88
Oestrogenreceptor beta expression and immunoreacivity 88
Prdm12 in health and diseases 83
Totale 13.081
Categoria #
all - tutte 42.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.628


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021500 0 0 0 0 0 20 126 95 23 122 86 28
2021/2022795 57 17 15 39 242 10 15 17 25 66 72 220
2022/20231.836 169 64 26 185 187 156 17 128 806 23 39 36
2023/2024814 77 34 48 100 186 64 38 48 18 22 63 116
2024/20251.793 15 56 48 119 285 260 262 136 178 175 170 89
2025/20265.521 350 443 352 299 617 3.460 0 0 0 0 0 0
Totale 13.461